NasdaqGS:ALKSBiotechs
Is It Time To Reassess Alkermes (ALKS) After Strong Recent Share Price Gains
If you are wondering whether Alkermes at around US$35.40 still offers value, it helps to step back and look at what the recent share performance might be implying about expectations.
The stock has returned 5.0% over the last 7 days, 7.2% over 30 days, 25.3% year to date and 16.5% over the past year. This puts recent pricing in clear focus for anyone weighing upside against risk.
Recent coverage has centered on Alkermes’ position in the pharmaceuticals and biotech space and how its pipeline...